Article Information
History
- May 19, 2020.
Article Versions
- You are currently viewing Version 1 of this article (May 19, 2020 - 02:09).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- P. Giorgi Rossi1,*,
- E. Ferroni2,*,
- S. Spila Alegiani3,**,
- G. Pitter2,
- O. Leoni4,
- D. Cereda4,
- M. Marino1,
- M. Pellizzari2,
- J. Sultana5,
- G. Trifirò5,
- M. Massari1,
- the ITA-COVID19 working group
- 1Azienda Unità Sanitaria Locale – IRCC, Reggio Emilia, Italy
- 2Azienda Zero of the Veneto Region, Padua, Italy
- 3Pharmacoepidemiology Unit – Italian National Institute of Health, Rome, Italy
- 4Department of Health of Lombardy Region, Milan, Italy
- 5Department of Biomedical and Dental Sciences and Morphofunctional Imaging – University of Messina, Messina, Italy
- ↵**Corresponding author
Dr Stefania Spila Alegiani, MSc Email: stefania.spila{at}iss.it; Tel. +39 0649904249; Address: Italian National Institute of Health, National Center for Drug Research and Evaluation, Pharmacoepidemiology Unit, Viale Regina Elena 299, 00161 Rome, Italy
↵* Contributed equally
Posted May 19, 2020.
Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID19 Network
